MedPath

The Efficacy Of The Unified Transdiagnostic Treatment for Irritable Bowel Syndrome

Not Applicable
Conditions
Irritable bowel syndrome.
irritable colon
Registration Number
IRCT2017010431765N1
Lead Sponsor
Vice chancellor for research of Kashan University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

diagnosis IBS based on the criteria of Rome III; aged between 18 and 40 years; satisfaction and commitment to participate in the study
Exclusion criteria: get interventions psychological treatment in the past year and the time of the study; history of alcohol abuse or drugs; two sessions of absence for each patient.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: subscale depression dass-42.;Anxiety. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: subscale anxiety dass-42.;Stress. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: subscale stress dass-42.;Emotion regulation. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: emotion regulation questionnaire.;Severity of symptoms in patients with irritable bowel syndrome. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: IBS Symptom Severity Scoring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath